Vistin Pharma ASA (VISTN) — Working Capital to Net Assets Ratio
Vistin Pharma ASA (VISTN) has a Working Capital to Net Assets ratio of 26.0% as of June 2025. Working capital of Nkr76.64 Million (current assets of Nkr181.79 Million minus current liabilities of Nkr105.15 Million) is measured against net assets of Nkr294.27 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Vistin Pharma ASA net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Vistin Pharma ASA Working Capital to Net Assets (2016–2024)
This chart shows how Vistin Pharma ASA's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 26.0%, reflecting working capital of Nkr76.64 Million against net assets of Nkr294.27 Million NOK. Check tangible net worth ratio of Vistin Pharma ASA to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Vistin Pharma ASA (2016–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Vistin Pharma ASA from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see VISTN market cap overview.
| Year | WC/NA Ratio | Working Capital (NOK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 25.6% | Nkr79.22 Million | Nkr309.53 Million | Nkr143.19 Million | Nkr63.97 Million | ▼ -5.2 pp |
| 2023 | 30.8% | Nkr99.30 Million | Nkr322.77 Million | Nkr168.77 Million | Nkr69.47 Million | ▲ +15.2 pp |
| 2022 | 15.5% | Nkr42.44 Million | Nkr273.26 Million | Nkr154.11 Million | Nkr111.67 Million | ▼ -19.6 pp |
| 2021 | 35.1% | Nkr96.80 Million | Nkr275.89 Million | Nkr137.83 Million | Nkr41.03 Million | ▼ -5.0 pp |
| 2020 | 40.1% | Nkr109.32 Million | Nkr272.40 Million | Nkr141.53 Million | Nkr32.20 Million | ▼ -37.6 pp |
| 2019 | 77.7% | Nkr321.39 Million | Nkr413.40 Million | Nkr394.63 Million | Nkr73.24 Million | ▲ +4.7 pp |
| 2018 | 73.1% | Nkr254.96 Million | Nkr348.85 Million | Nkr389.29 Million | Nkr134.33 Million | ▲ +20.5 pp |
| 2017 | 52.6% | Nkr63.21 Million | Nkr120.16 Million | Nkr160.06 Million | Nkr96.85 Million | ▼ -25.3 pp |
| 2016 | 77.9% | Nkr145.35 Million | Nkr186.61 Million | Nkr225.97 Million | Nkr80.62 Million | — |